Unknown

Dataset Information

0

SCG2 is a Prognostic Biomarker Associated With Immune Infiltration and Macrophage Polarization in Colorectal Cancer.


ABSTRACT: Colorectal cancer (CRC) is the second most lethal malignancy around the world. Limited efficacy of immunotherapy creates an urgent need for development of novel treatment targets. Secretogranin II (SCG2) is a member of the chromogranin family of acidic secretory proteins, has a role in tumor microenvironment (TME) of lung adenocarcinoma and bladder cancer. Besides, SCG2 is a stroma-related gene in CRC, its potential function in regulating tumor immune infiltration of CRC needs to be fully elucidated. In this study, we used western blot, real-time PCR, immunofluorescence and public databases to evaluate SCG2 expression levels and distribution. Survival analysis and functional enrichment analysis were performed. We examined TME and tumor infiltrating immune cells using ESTIMATE and CIBERSORT algorithm. The results showed that SCG2 expression was significantly decreased in CRC tumor tissues, and differentially distributed between tumor and adjacent normal tissues. SCG2 was an independent prognostic predictor in CRC. High expression of SCG2 correlated with poor survival and advanced clinical stage in CRC patients. SCG2 might regulate multiple tumor- and immune-related pathways in CRC, influence tumor immunity by regulating infiltration of immune cells and macrophage polarization in CRC.

SUBMITTER: Wang H 

PROVIDER: S-EPMC8763391 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10559510 | biostudies-literature
| S-EPMC7247806 | biostudies-literature
| S-EPMC10071625 | biostudies-literature
| S-EPMC10988317 | biostudies-literature
| S-EPMC7785652 | biostudies-literature
| S-EPMC10713618 | biostudies-literature
| S-EPMC10636683 | biostudies-literature
| S-EPMC8818961 | biostudies-literature
| S-EPMC7801710 | biostudies-literature